Mutation status of RAD 51C , PALB 2 and BRIP 1 in 100 Japanese familial breast cancer cases without BRCA 1 and BRCA 2 mutations
Autor: | Yoshio Miki, Yuri Sato, Sachio Nomura, Eri Nakashima, Shinji Ohno, Masami Arai, Reiko Yoshida, Mizuho Kita, Takuji Iwase, Yasue Adachi, Yuumi Ashihara, Dai Kitagawa, Katsutoshi Sato, Mio Koyasu |
---|---|
Rok vydání: | 2017 |
Předmět: |
0301 basic medicine
Proband Genetics Cancer Research Mutation business.industry PALB2 General Medicine medicine.disease_cause medicine.disease 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Breast cancer Oncology 030220 oncology & carcinogenesis Cancer research Medicine RAD51C Missense mutation Mutation frequency skin and connective tissue diseases business Ovarian cancer |
Zdroj: | Cancer Science. 108:2287-2294 |
ISSN: | 1349-7006 1347-9032 |
DOI: | 10.1111/cas.13350 |
Popis: | In addition to BRCA1 and BRCA2, RAD51C, PALB2 and BRIP1 are known as breast cancer susceptibility genes. However, the mutation status of these genes in Japanese familial breast cancer cases has not yet been evaluated. To this end, we analyzed the exon sequence and genomic rearrangement of RAD51C, PALB2 and BRIP1 in 100 Japanese patients diagnosed with familial breast and ovarian cancer and without BRCA1 and BRCA2 mutations. We detected a large deletion from exons 6 to 9 in RAD51C, 4 novel BRIP1 missense variants containing 3 novel non-synonymous variants, c.89A>C, c.736A>G and c.2131A>G, and a splice donor site variant c.918+2T>C. No deleterious variant of PALB2 was detected. The results of pedigree analysis showed that the proband with a large deletion on RAD51C had a family history of both breast and ovarian cancer, and the families of probands with novel BRIP1 missense variants included a male patient with breast cancer or many patients with breast cancer within the second-degree relatives. We showed that the mutation frequency of RAD51C in Japanese familial breast cancer cases was similar to that in Western countries and that the prevalence of deleterious mutation of PALB2 was possibly lower. Furthermore, our results suggested that BRIP1 mutation frequency in Japan might differ from that in Western countries. |
Databáze: | OpenAIRE |
Externí odkaz: |